Basic Study
Copyright ©The Author(s) 2021.
World J Diabetes. Apr 15, 2021; 12(4): 453-465
Published online Apr 15, 2021. doi: 10.4239/wjd.v12.i4.453
Figure 4
Figure 4 Glucagon-like peptide 1, fasting serum lipopolysaccharide, and total bile acids levels. A-D: Fasting serum glucagon-like peptide 1 levels measured at baseline and 2, 12, and 24 wk after surgery. The P value is shown in a rectangular frame; E: Fasting serum lipopolysaccharide; F: Total bile acids [aP < 0.01, bP < 0.001, SHAM vs sleeve gastrectomy (SG); cP < 0.001, SHAM vs SG-oligofructose (SG-OF); dP < 0.05, eP < 0.01, SG vs SG-OF]. A statistically significant difference was considered at P < 0.05. GLP-1: Glucagon-like peptide 1; LPS: Lipopolysaccharide; TBA: Total bile acids; SG-OF: Sleeve gastrectomy-oligofructose.